Significant Ownership of Newpath Partners, L.P.
- Signature - Title
- By: Newpath Partners GP, L.P. By: /s/ Thomas Cahill - Thomas Cahill, Managing Member
- Location
- Andover, MA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Newpath Partners, L.P..
Follow Filing Activity
Follow Newpath Partners, L.P. and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Newpath Partners, L.P.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PRME | Prime Medicine, Inc. | Common Stock, par value $0.00001 per share | 4.7% | $9,769,086 | 6,105,679 | Newpath Partners, L.P. | 31 Dec 2024 |
Schedules 13D/G Reported by Newpath Partners, L.P.:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.